Cardiovascular Division, Washington University School of Medicine, St Louis, MO
Center for Value and Innovation, Washington University School of Medicine, St Louis, MO.
J Am Heart Assoc. 2018 Feb 15;7(4):e005733. doi: 10.1161/JAHA.117.005733.
Same-day discharge (SDD) after elective percutaneous coronary intervention is safe, less costly, and preferred by patients, but it is usually performed in low-risk patients, if at all. To increase the appropriate use of SDD in more complex patients, we implemented a "patient-centered" protocol based on risk of complications at Barnes-Jewish Hospital.
Our objectives were as follows: (1) to evaluate time trends in SDD; (2) to compare (a) mortality, bleeding, and acute kidney injury, (b) patient satisfaction, and (c) hospital costs by SDD versus no SDD (NSDD); and (3) to compare SDD eligibility by our patient-centered approach versus Society for Cardiovascular Angiography and Interventions guidelines. Our patient-centered approach was based on prospectively identifying personalized bleeding, mortality, and acute kidney injury risks, with a personalized safe contrast limit and mitigating those risks. We analyzed Barnes-Jewish Hospital's National Cardiovascular Data Registry CathPCI Registry data from July 1, 2009 to September 30, 2015 (N=1752). SDD increased rapidly from 0% to 77% (<0.001), independent of radial access. Although SDD patients were comparable to NSDD patients, SDD was not associated with adverse outcomes (0% mortality, 0% bleeds, and 0.4% acute kidney injury). Patient satisfaction was high with SDD. Propensity score-adjusted costs were $7331 lower/SDD patient (<0.001), saving an estimated $1.8 million annually. Only 16 patients (6.95%) met the eligibility for SDD by Society for Cardiovascular Angiography and Interventions guidelines, implying our patient-centered approach markedly increased SDD eligibility.
With a patient-centered approach, SDD rapidly increased and was safe in 75% of patients undergoing elective percutaneous coronary intervention, despite patient complexity. Patient satisfaction was high, and hospital costs were lower. Patient-centered decision making to facilitate SDD is an important opportunity to improve the value of percutaneous coronary intervention.
择期经皮冠状动脉介入治疗后的当日出院(SDD)安全、成本低,并且受到患者的青睐,但通常仅在低风险患者中实施,如果有的话。为了在更复杂的患者中增加 SDD 的合理使用,我们在巴恩斯-犹太医院实施了一项基于并发症风险的“以患者为中心”的方案。
我们的目标如下:(1)评估 SDD 的时间趋势;(2)比较(a)死亡率、出血和急性肾损伤,(b)患者满意度,以及(c)SDD 与非 SDD(NSDD)的住院费用;(3)比较我们以患者为中心的方法与心血管造影和介入学会指南对 SDD 适应证的评估。我们以患者为中心的方法是基于前瞻性地确定个性化的出血、死亡率和急性肾损伤风险,以及个性化的安全造影剂限制,并降低这些风险。我们分析了 2009 年 7 月 1 日至 2015 年 9 月 30 日巴恩斯-犹太医院国家心血管数据注册经皮冠状动脉介入治疗登记处的数据(N=1752)。SDD 从 0%快速增加到 77%(<0.001),与桡动脉入路无关。尽管 SDD 患者与 NSDD 患者相似,但 SDD 与不良结局无关(死亡率为 0%,出血率为 0%,急性肾损伤率为 0.4%)。患者对 SDD 的满意度很高。经倾向评分调整后,SDD 患者的费用降低了 7331 美元/人(<0.001),每年可节省约 180 万美元。只有 16 名患者(6.95%)符合心血管造影和介入学会指南的 SDD 适应证,这意味着我们以患者为中心的方法明显增加了 SDD 的适应证。
通过以患者为中心的方法,在接受择期经皮冠状动脉介入治疗的患者中,75%的患者可以快速安全地进行 SDD,尽管患者的病情复杂。患者满意度高,住院费用降低。以患者为中心的决策促进 SDD 是提高经皮冠状动脉介入治疗价值的重要机会。